IP Library Granted Patent US 9,107,820
Granted Patent B2
US 9,107,820 · App. 14/312,189 · Granted Aug 18, 2015

Device for delivery of a substance

Inventors: Martin Mintchev (Calgary, CA); Orly Yadid-Pechet (Calgary, CA); Michel Fattouche (Calgary, CA)
Assignee: EatLittle Inc.
A61K9/0065A61K9/009A61L31/146A61M31/00A61M31/002A61M29/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,107,820
App. No.
14/312,189
Granted
Aug 18, 2015
Kind
B2
Abstract

A device for delivering a substance in situ in a body comprising at least one permeable expandable container having a first dimension and a second dimension and having contained therein the substance to be delivered; and at least one expandable particle comprising a swellable material contained within the container and capable of expanding when contacted with a fluid; whereby when the device is positioned in situ, bodily fluid permeates the container causing the at least one expandable particle contained therein to swell and the container to expand from the first dimension to the second dimension so that the device remains in situ for a period of time sufficient to achieve the desired delivery of the substance is provided.

Claims (8)

1. A device for delivering a pharmaceutical substance in situ in a body, the device comprising

(a) a carrier ( 212 ),

(b) coupling members ( 274 ) for releaseably coupling containers to the carrier ( 212 ),

(c) at least one permeable expandable container ( 276 ) having a first dimension and a second dimension and containing at least one expandable particle ( 222 ) comprising a swellable material capable of expanding when contacted with a bodily fluid to expand the container from the first dimension to the second dimension so that the device remains in situ for a period of time sufficient to achieve the desired delivery of the pharmaceutical substance; and

(d) at least one substance-holding container ( 277 ) consisting essentially of a biocompatible sac and the pharmaceutical substance to be delivered.

2. The device as claimed in claim 1 , wherein the coupling member ( 274 ) is selected from the group comprising an absorbable biodegradable surgical suture, a piece of biodegradable medical gauze, an absorbable net-like nanostructure, biocompatible glue or combinations thereof.

3. The device as claimed in claim 1 , wherein the carrier ( 212 ) further comprises a controller ( 298 ) for controlling the release of the pharmaceutical substance from the at least one substance-holding container ( 277 ).

4. The device as claimed in claim 1 , wherein the pharmaceutical substance is in the form of a substance-carrying particle ( 223 ).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2015
From: MINTCHEV, MARTIN PAVLOV; YADID-PECHT, ORLY
To: ELECTRONIC DIETARY FOODS INC.
Reel/Frame 035881/0743 →
CHANGE OF NAME Recorded Jun 23, 2015
From: ELECTRONIC DIETARY FOODS INC.
To: EATLITTLE INC.
Reel/Frame 036012/0681 →
Continuity (3)
Division 12517752
Provisional Application 60875311 · Dec 18, 2006
Related Publication 20140330210A1 · Nov 6, 2014